Amgen Inc.

32 drugs in NADAC|0 Generic,32 Brand

Amgen Inc. lists 32 NDCs in the CMS NADAC file (0 generic, 32 brand), at an average NADAC of $875.18 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

0G / 32B

Avg Price / Unit

$875.1836

$10.00 – $10074.86

Avg 7d Change

-0.02%

Across 9 drugs with changes

7d Activity

3↑6↓23 flat

of 32 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Lead market

darbepoetin alfa market

See the molecule this manufacturer shows up in most often and compare it against competing suppliers.

Lead class

Erythropoiesis-stimulating Agent therapeutic class

Review the broader class where Amgen Inc. has the strongest current portfolio footprint.

Trend hub

Portfolio trend view

Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.

Guide

NADAC pricing primer

Use the explainer for context on the benchmark this manufacturer is being compared against.

Frequently Asked Questions

How many drugs does Amgen Inc. make?

Amgen Inc. lists 32 NDCs in the CMS NADAC file — 0 generic and 32 brand products.

What is the average price of Amgen Inc. drugs?

The average NADAC across Amgen Inc.'s portfolio is $875.1836 per unit, ranging from $9.9977 to $10074.8571.

What types of drugs does Amgen Inc. make?

Amgen Inc. makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are Erythropoiesis-stimulating Agent (9), Leukocyte Growth Factor (5), RANK Ligand Inhibitor (4), PCSK9 Inhibitor (4), Calcium-sensing Receptor Agonist (3).

Has Amgen Inc. had any drug recalls?

No FDA enforcement recalls are matched to Amgen Inc. in the openFDA feed.

How has Amgen Inc.'s pricing changed recently?

Over the past 7 days, 3 Amgen Inc. products rose and 6 fell, with a portfolio-wide average change of -0.0%.

Drug Portfolio

32 drugs total, 32 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
NEULASTA 6 MG/0.6 ML SYRINGE pegfilgrastim	55513019001	$10074.8571 per ML	—	Brand	—	Leukocyte Growth Factor
XGEVA 120 MG/1.7 ML VIAL denosumab	55513073001	$2001.5168 per ML	—	Brand	—	RANK Ligand Inhibitor
XGEVA 120 MG/1.7 ML VIAL denosumab	55513073021	$2001.5168 per ML	—	Brand	—	RANK Ligand Inhibitor
PROLIA 60 MG/ML SYRINGE denosumab	55513071021	$1862.7440 per ML	-0.05%	Brand	—	RANK Ligand Inhibitor
PROLIA 60 MG/ML SYRINGE denosumab	55513071001	$1862.7440 per ML	-0.05%	Brand	—	RANK Ligand Inhibitor
ARANESP 60 MCG/0.3 ML SYRINGE darbepoetin alfa	55513002304	$1500.1469 per ML	-0.07%	Brand	—	Erythropoiesis-stimulating Agent
ARANESP 100 MCG/0.5 ML SYRINGE darbepoetin alfa	55513002504	$1427.5279 per ML	—	Brand	—	Erythropoiesis-stimulating Agent
AIMOVIG 70 MG/ML AUTOINJECTOR erenumab-aooe	55513084101	$753.5710 per ML	0.00%	Brand	—	—
AIMOVIG 140 MG/ML AUTOINJECTOR erenumab-aooe	55513084301	$753.3259 per ML	-0.01%	Brand	—	—
ARANESP 40 MCG/0.4 ML SYRINGE darbepoetin alfa	55513002104	$752.4362 per ML	—	Brand	—	Erythropoiesis-stimulating Agent
NEUPOGEN 300 MCG/0.5 ML SYR Filgrastim	55513092491	$650.0520 per ML	—	Brand	—	Leukocyte Growth Factor
NEUPOGEN 480 MCG/0.8 ML SYR Filgrastim	55513020910	$636.0120 per ML	—	Brand	—	Leukocyte Growth Factor
NEUPOGEN 300 MCG/0.5 ML SYR Filgrastim	55513092410	$632.3279 per ML	—	Brand	—	Leukocyte Growth Factor
ARANESP 25 MCG/0.42 ML SYRING darbepoetin alfa	55513005704	$446.5774 per ML	-0.11%	Brand	—	Erythropoiesis-stimulating Agent
EPOGEN 20,000 UNITS/ML VIAL epoetin alfa	55513047810	$320.1466 per ML	—	Brand	—	Erythropoiesis-stimulating Agent
NEUPOGEN 300 MCG/ML VIAL Filgrastim	55513053010	$304.0908 per ML	—	Brand	—	Leukocyte Growth Factor
REPATHA 140 MG/ML SURECLICK Evolocumab	72511076002	$281.9611 per ML	0.00%	Brand	—	PCSK9 Inhibitor
REPATHA 140 MG/ML SURECLICK Evolocumab	72511039302	$281.9611 per ML	0.00%	Brand	—	PCSK9 Inhibitor
REPATHA 140 MG/ML SYRINGE Evolocumab	72511050101	$281.8058 per ML	—	Brand	—	PCSK9 Inhibitor
REPATHA 140 MG/ML SYRINGE Evolocumab	72511075001	$281.8058 per ML	—	Brand	—	PCSK9 Inhibitor
ARANESP 25 MCG/ML VIAL darbepoetin alfa	55513000204	$185.3625 per ML	—	Brand	—	Erythropoiesis-stimulating Agent
EPOGEN 10,000 UNIT/ML VIAL epoetin alfa	55513014410	$161.8001 per ML	—	Brand	—	Erythropoiesis-stimulating Agent
OTEZLA 10-20-30 MG START 28 DAY apremilast	55513036955	$98.5508 per EA	—	Brand	—	—
OTEZLA 30 MG TABLET apremilast	55513013760	$90.5717 per EA	+0.03%	Brand	—	Phosphodiesterase 4 Inhibitor
OTEZLA 20 MG TABLET apremilast	55513049760	$89.9522 per EA	—	Brand	—	Phosphodiesterase 4 Inhibitor
SENSIPAR 90 MG TABLET cinacalcet hydrochloride	55513007530	$78.2590 per EA	—	Brand	—	Calcium-sensing Receptor Agonist
EPOGEN 4,000 UNIT/ML VIAL epoetin alfa	55513014810	$64.3638 per ML	—	Brand	—	Erythropoiesis-stimulating Agent
SENSIPAR 60 MG TABLET cinacalcet hydrochloride	55513007430	$51.7723 per EA	—	Brand	—	Calcium-sensing Receptor Agonist
EPOGEN 2,000 UNITS/ML VIAL epoetin alfa	55513012610	$32.2669 per ML	-0.02%	Brand	—	Erythropoiesis-stimulating Agent
SENSIPAR 30 MG TABLET cinacalcet hydrochloride	55513007330	$25.8397 per EA	—	Brand	—	Calcium-sensing Receptor Agonist
CORLANOR 5 MG TABLET ivabradine	55513080060	$10.0105 per EA	+0.02%	Brand	High Outlier	Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker
CORLANOR 7.5 MG TABLET ivabradine	55513081060	$9.9977 per EA	+0.06%	Brand	High Outlier	Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker